These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1003558)

  • 1. Screening of cytotoxic drugs for residual bone marrow damage.
    Trainor KJ; Morley AA
    J Natl Cancer Inst; 1976 Dec; 57(6):1237-9. PubMed ID: 1003558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The problem of permanent bone marrow damage after cytotoxic drug treatment.
    Lohrmann HP
    Oncology; 1984; 41(3):180-4. PubMed ID: 6374556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of acute chemotherapy-induced death in mice by recombinant human interleukin 1: protection from hematological and nonhematological toxicities.
    Damia G; Komschlies KL; Futami H; Back T; Gruys ME; Longo DL; Keller JR; Ruscetti FW; Wiltrout RH
    Cancer Res; 1992 Aug; 52(15):4082-9. PubMed ID: 1638519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effects of tumor necrosis factor on murine hematopoiesis during cycle-specific cytotoxic chemotherapy.
    Slørdal L; Warren DJ; Moore MA
    Cancer Res; 1990 Jul; 50(14):4216-20. PubMed ID: 2364379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
    Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
    Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sensitivities of human and murine hemopoietic cells exposed to cytotoxic drugs in an in vivo culture system.
    Gordon MY; Blackett N
    Cancer Res; 1976 Aug; 36(8):2822-6. PubMed ID: 1277192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of cytotoxic agents on hematopoietic progenitors.
    Botnick LE; Hannon EC; Vigneulle R; Hellman S
    Cancer Res; 1981 Jun; 41(6):2338-42. PubMed ID: 7237432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemotoxicity of busulphan, doxorubicin, cisplatin and cyclophosphamide in the female BALB/c mouse using a brief regimen of drug administration.
    Molyneux G; Andrews M; Sones W; York M; Barnett A; Quirk E; Yeung W; Turton J
    Cell Biol Toxicol; 2011 Feb; 27(1):13-40. PubMed ID: 20589437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The toxic action of antineoplastic chemotherapeutic agents evaluated by study of hemopoietic stem cells].
    Pannacciulli I; Ghio R; Bianchi G; Bogliolo G; Saviane A; Massa G
    Minerva Med; 1978 Dec; 69(61):4257-65. PubMed ID: 366466
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the effect of some antineoplastic agents after erythropoietic stimulation].
    Bogliolo G; Saviane A; Massa G; Ghio R; Bianchi G; Pannacciulli I
    Tumori; 1976; 62(4):445-54. PubMed ID: 1020051
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of latent residual drug damage to the hematopoietic marrow during the subsequent growth of tumors.
    Kovacs CJ; Johnke RM; Evans MJ; Emma DA; Hooker JL
    Exp Hematol; 1986 Mar; 14(3):165-72. PubMed ID: 3948928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More than additive toxicity of the combination of 1-methyl-1-nitrosourea plus 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat.
    Zeller WJ; Berger MR; Henne T; Weber E
    Cancer Res; 1986 Apr; 46(4 Pt 1):1714-6. PubMed ID: 3948161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The A.H.E.A.D. method: a quantitative automated measurement of the hematotoxicity of anticancer drugs.
    Saint-Dizier D; Sancier M; Cudennec CA
    Anticancer Res; 1990; 10(3):765-71. PubMed ID: 2369090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin-induced sensitivity of hematopoietic stem cells to chemotherapeutic agents.
    Eaves AC; Bruce WR
    Ser Haematol; 1972; 5(2):64-72. PubMed ID: 5056787
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytotoxic drugs and the granulopoietic system.
    Lohrmann HP; Schreml W
    Recent Results Cancer Res; 1982; 81():1-222. PubMed ID: 6173905
    [No Abstract]   [Full Text] [Related]  

  • 16. The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.
    Bedford P; Berger MR; Eisenbrand G; Schmähl D
    J Cancer Res Clin Oncol; 1984; 108(1):141-7. PubMed ID: 6235230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary toxicity of cytostatic drugs: cell kinetics.
    Witschi H; Godfrey G; Frome E; Lindenschmidt RC
    Fundam Appl Toxicol; 1987 Feb; 8(2):253-62. PubMed ID: 3556836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell defects after cytoreductive therapy in man.
    Schreml W; Lohrmann HP; Anger B
    Exp Hematol; 1985; 13 Suppl 16():31-42. PubMed ID: 2985415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of chlorozotocin and BCNU on hematopoietic precursor cells.
    Horikoshi A; Smith R; Murphy MJ
    Chemotherapy; 1983; 29(2):135-44. PubMed ID: 6220871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical structure of carbamoylating groups and their relationship to bone marrow toxicity and antiglioma activity of bifunctionally alkylating and carbamoylating nitrosoureas.
    Ali-Osman F; Giblin J; Berger M; Murphy MJ; Rosenblum ML
    Cancer Res; 1985 Sep; 45(9):4185-91. PubMed ID: 2411398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.